Boeing faced a turbulent day as its shares slipped 1.3% following the release of preliminary fourth-quarter financial results that highlighted ongoing challenges. The aerospace giant reported revenue of $3.54 billion, slightly below the $3.56 billion forecasted by analysts from FactSet. Meanwhile, Twilio saw its shares rally nearly 18% after issuing an optimistic long-term forecast at a Thursday investor event. In contrast, Texas Instruments exceeded Wall Street expectations for both earnings and revenue in the recently concluded quarter.
Intuitive Surgical's shares fell by 2% after the company released a forecast for 2025 indicating a potential shrinkage in a key profit margin. CSX also experienced a decline, with shares slipping 3.5% following an announcement that revenue had fallen in the last quarter. The drop was attributed to a lower fuel surcharge and reduced coal revenue.
Boeing's financials revealed an expected fourth-quarter loss of $5.46 per share on revenue totaling $15.2 billion. The company likely burned through $3.5 billion in cash during the quarter, in part due to a labor strike and a new workforce agreement. On the other hand, CSX posted in-line earnings of 42 cents per share, excluding one-time items, aligning with expectations from analysts polled by FactSet.
Novo Nordisk's U.S.-listed shares soared 14% after announcing promising early-stage trial results for its once-weekly amycretin obesity drug. The trial showed an average weight reduction of 22% in obese and overweight patients after 36 weeks, boosting investor confidence.
Twilio's positive outlook included an adjusted operating margin prediction of up to 22% by 2027, surpassing Wall Street's consensus and the latest quarter's margin of 16.1%. This optimistic future was further bolstered by Baird's upgrade of Twilio's stock to outperform from neutral, signaling confidence ahead of the company's fourth-quarter results.
Texas Instruments provided estimates for the current quarter's profit, ranging from 94 cents to $1.16 per share, slightly below the $1.17 per share estimated by analysts surveyed by LSEG.
Intuitive Surgical adjusted its gross profit margin expectations for 2025 to range between 67% and 68%, down from the previous expectation of 69.1% in 2024.